Table 5 Test performance for secondary outcome (Death or Cancer)
From: Predictive score for estimating cancer after venous thromboembolism: a cohort study
Score points | Sensitivity (CI 95%) | Specificity (CI 95%) | NPV (CI 95%) | PPV (CI 95%) | LLR+ (CI 95%) | LLR- (CI 95%) |
|---|---|---|---|---|---|---|
≥1 | 0.98 (0.92-0.99) | 0.14 (0.11-0.19) | 0.95 (0.82-0.99) | 0.28 (0.27-0.30) | 1.1 (1.1-1.2) | 0.15 (0.037-0.61) |
≥ 2 | 0.88 (0.80-0.93) | 0.44 (0.39-0.51) | 0.91 (0.85-0.95) | 0.36 (0.33-0.38) | 1.5 (1.4-1.8) | 0.27 (0.15 -0.47) |
≥ 3 | 0.52 (0.42-0.62) | 0.72 (0.66-0.77) | 0.81 (0.77-0.84) | 0.40 (0.33-0.46) | 1.9 (1.4-2.5) | 0.66 (0.53-0.83) |
≥ 4 | 0.32 (0.24-0.43) | 0.93 (0.89-0.96) | 0.79 (0.77-0.81) | 0.41 (0.25-0.56) | 4.7 (2.7-7.9) | 0.73 (0.63-0.84) |
≥ 5 | 0.18 (0.12-0.27) | 0.98 (0.97-1) | 0.77 (0.75-0.78) | 0.85 (0.62-0.96) | 15 (4.7-52) | 0.82 (0.75-0.91) |